The Geneus Biotech venture started in 2017 with the idea of using the founder’s IP on growing human hair follicles on other related areas such as precious fur and luxury wool. Developing the science and technology behind the products has been a challenging journey. However, when the company in 2022 received a 4 million EUR grant from the EU Commission, it was an important validation of the scientific results and a tremendous boost for the project. Moving forward the science team will be strongly increased to support the R&D projects and the task of upscaling to commercial production.
On the business side, a small, dedicated team will focus on potential clients and attracting new investors to the company.